ScholarIQanswers from OpenAlex
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
PaperCitations, authors & open-access status
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer have?
ScholarIQcitation count
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer has 733 citations in the OpenAlex counts ScholarIQ stores.
When was Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer published?
ScholarIQyear
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer has 2023 year in the ScholarIQ index.
What is the open-access status of Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer?
ScholarIQoa status
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer has green oa status in the ScholarIQ index.
What is the DOI of Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer?
ScholarIQdoi
The DOI for Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer is on the source record.
What is the PMID of Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer?
ScholarIQpmid
The PMID for Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer is on the source record.
What is the OpenAlex record for Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer?
ScholarIQopenalex
The OpenAlex for Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer is on the source record.